While some chains are rapidly expanding their scan-based trading programs, others are still taking a wait-and-see approach. After years of tests on scan-based trading, supermarkets continue to ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

Guardant Health said its blood test to detect a cancer that starts in the colon or rectum got an approval from the US Food and Drug Administration, sending the company’s shares up 16% in premarket ...

Some supermarkets are taking a few hesitant steps toward scan-based trading of magazines, but many in the industry are starting to question whether the system, in which retailers pay for their ...